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EDITORIAL
Embracing the fistula first national vascular access
improvement initiative
Britt H. Tonnessen, MD, and Samuel R. Money, MD, New Orleans, LaIn the United States, the number of end-stage renal
disease (ESRD) patients on hemodialysis (HD) exceeds
300,000 and increases exponentially each year. Creating a
functional and durable vascular access for these patients
must be a priority. The gold standard for HD access is
unambiguously the autogenous arteriovenous fistula
(AVF). AVFs are more resistant to infection and have
superior patency rates compared with prosthetic arterio-
venous grafts (AVGs) or catheters.1,2 In addition, patients
with an AVF may experience a survival benefit relative to
patients with a catheter or AVG.3 Despite these clear ben-
efits, AVFs remain underutilized as hemodialysis access.
Optimal vascular access was highlighted in a comprehensive
treatise from the National Kidney Foundation, the updated
2000 Kidney Disease Outcomes Quality Initiative (K/
DOQI™) guidelines.4 Specific goals include
1. Primary AVF placement in at least 50% of incident (new)
HD patients
2. AVF use in at least 40% of prevalent (existing) HD
patients
3. Chronic catheter (3months) use in10% of prevalent
HD patients
In a cross-sectional study of international dialysis pa-
tients from 2002-2003, AVF use reached upward of 80% in
Europe and 90% in Japan.5 In contrast, AVF use across the
United States has virtually stagnated just above 30% since
the early 1990s.6 Although isolated centers have reported
greatly improved AVF placement after adapting
K/DOQI™ guidelines,7 the regional and nationwide re-
sponse has been negligible. On the heels of K/DOQI™,
the Centers ofMedicare andMedicaid Services (CMS) have
sponsored the 2003-2006 Fistula First National Vascular
Access Improvement Initiative (NVAII) with the chief aim
of increasing AVF use. The Fistula First Change Package
identifies 11 strategies geared at multidisciplinary improve-
From the Department of Vascular Surgery, Ochsner Clinic Foundation.
Competition of interest: none.
Reprint requests: Britt Hansen Tonnessen, Department of Vascular Surgery,
Ochsner Clinic Foundation, 1516 Jefferson Hwy, New Orleans, LA
70123 (e-mail: tonnessen_britt@hotmail.com).
J Vasc Surg 2005;42:585-6
0741-5214/$30.00
Copyright © 2005 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.05.030ments.8 Listed below are a few Fistula First tactics geared
toward obstacles in AVF placement from a surgical perspec-
tive.
EARLY REFERRAL TO SURGEON FOR
“AVF-ONLY” EVALUATION AND TIMELY
PLACEMENT
Patients benefit when surgical referral occurs at least
several months in advance of dialysis dependence. How-
ever, referral delays may inappropriately bias the surgeon
toward placing an AVG in order to expedite “permanent”
access. In this situation, it is preferable to place a cuffed
catheter for dialysis while awaiting AVF maturation.4 The
ultimatum-like request for “AVF only” is perhaps a bit
contentious. Nonetheless, this statement should not be
offsetting to the surgeon’s autonomy, but merely a re-
minder of the preeminence of AVFs.
SURGEON SELECTION BASED ON BEST
OUTCOMES, WILLINGNESS, AND ABILITY TO
PERFORM ACCESS SERVICES
This statement appeals to the Darwinian concept of
“adapt and compete” (or become extinct). Because access
surgery requires significant commitment to quality im-
provement, inevitably those surgeons who prioritize AVF
placement will become preferred providers.
FULL RANGE OF APPROPRIATE SURGICAL
APPROACHES TO AVF EVALUATION AND
PLACEMENT
The spectrum of “permanent” access options should
not be limited to the Cimino fistula, forearm AVG, and
upper arm AVG. Versatility and generous use of upper arm
fistulas and venous transposition techniques, as well as
endovascular techniques for access salvage, should be part
of our armamentarium. We discourage the practice of
placing AVGs in order to offer a shorter operation or
smaller incisions. Another rationale for preferential AVG
placement is the myth that veins not readily apparent on
physical examination are unsuitable for an AVF. Liberal use
of duplex vein mapping preoperatively can help identify
usable veins, sometimes in the upper or nondominant arm,
and significantly increase the placement of AVFs.9
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Every patient with a catheter or dysfunctional AVG
should be reconsidered for an AVF at every presentation.
Patients with multiple previous accesses especially deserve a
“fresh look.” Existing AVGs may result in arterialization
and dilation of upper arm veins that may become visually
apparent during dialysis sessions. Patients with failing
AVGs should be considered for “conversion” to AVFs.
Preoperative vein mapping for AVF placement can facilitate
this practice, but reimbursement (Medicare code G0365) is
limited to newHD patients twice per year. It is hoped that
future amendments will permit use in patients with previ-
ous accesses who may derive the most benefit from vein
mapping.
The ESRD Network is composed of 18 geographically
organized, nonprofit centers serving the dialysis commu-
nity under contract to the CMS.OurNetwork 13 serves the
ESRD population of 12,000 patients in Arkansas, Okla-
homa, and Louisiana. As part of the Fistula First NVAII,
Network 13 has developed and distributed practical Qual-
ity Improvement (QI) tools (letters, guides, presentations)
that support integration of each of the 11 Fistula First
strategies into clinical practice. Network 13 conducts phy-
sician and provider conferences on vascular access through-
out the region, on topics ranging from surgical techniques
to cannulation training. Network 13 personnel have been
instrumental in opening lines of communication with more
than 450 surgeons and interventionalists providing care to
ESRD patients and encouraging providers from different
disciplines to form multidisciplinary teams.
Since July 2003, vascular access data have been pro-
spectively collected on a monthly basis from all active
Network 13 dialysis facilities. This information is used to
monitor progress and provide feedback to the dialysis facil-
ities andQI committees. Initially, themajority (14 of 18) of
Networks fell below the K/DOQI™ goal for 40% AVF
prevalence, and our South Central region ranked 17th.
However, over a 1-year study period fromOctober 2003 to
September 2004, Network 13 increased AVF use from
27.2% to 30.9%, a percentage that continues to rise. As of
early 2005, Network 13 had surpassed two other networks
and had the fourth highest increase in AVF use. Neverthe-
less, AVF placement in incident patients (those new toHD)
averages about 20%, well below the K/DOQI™ 50% goal.
Another major concern that emerged from these data wasan excessive use of catheters. Among prevalent (existing)
HD patients, 30% dialyzed with a catheter and of these nearly
half were “chronic catheters” (used90 days). Furthermore,
6% of these patients had an AVF simultaneously maturing.
Nearly 75% of incident patients initiate HD with a catheter,
yet10% have an AVF simultaneously maturing.
In response to the Fistula First NVAII, our South
Central region and other regions have made significant
strides in improving vascular access, most notably by in-
creasing the prevalence of AVFs. The K/DOQI™ guide-
lines are reasonable goals that we will continue to work
toward, particularly by increasing AVF placement and de-
creasing chronic catheter use. Access surgeons should fa-
miliarize themselves with the Fistula First strategies and the
efforts of their regional ESRD Network. Ultimately, the
responsibility to improve vascular access rests with all pro-
viders to ESRD patients.
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